Indivior Pharmaceuticals

INDVNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.844 B

$38.82 +0.39%

Close of 7 Aug 2026

Revenue

$1.24B

#1404 by revenue

Earnings

$210.0M

#984 by earnings

Shares outstanding

118,013,649

Latest filing cover page

P/E ratio

23.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#59Acadia PharmaceuticalsACAD$5.03B
#60Dyne TherapeuticsDYN$4.90B
#61Indivior PharmaceuticalsINDV$4.84B
#62VeradermicsMANE$4.78B
#63Edgewise TherapeuticsEWTX$4.68B

Where these numbers come from

Share counts and financials for Indivior Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.